Clinical trial · Observational
Sexual Behavior in Head and Neck Cancer Patients
NCT00662662CI-TRIAL-00049177unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this behavioral research study is to learn if certain sexual behaviors increase the risk for developing head and neck cancers associated with a virus called human papillomavirus (HPV-16). Knowing this information could help doctors better teach patients about avoiding certain risk factors, which may help to prevent the disease.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Oropharyngeal Cancer | Malignant Oropharyngeal Neoplasm | CURATED_EXACT | 0.92 |
| Squamous Cell Carcinoma | Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Oropharyngeal Cancer
- interventionNames
- Behavioral: Questionnaire
- label
- Non-Oropharyngeal Cancer
- interventionNames
- Behavioral: Questionnaire
Primary outcomes (1)
- measure
- To find out if certain sexual behaviors increase the risk for developing head and neck cancers associated with a virus called human papillomavirus (HPV-16).
- timeFrame
- 6 Years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with newly diagnosed, previously untreated squamous cell carcinoma of the head and neck (SCCHN) who are candidates for the molecular epidemiology study LAB00-062 of head and neck cancer. 2. Must have the ability to understand and provide informed consent. 3. Patients must be 18 years and older. 4. Ability to read, write, and speak English. 5. Resident of the United States. 6. Agrees to have tumor tissue, if available, tested for HPV. No additional biopsy will be requested. Exclusion Criteria: 1. Previous cancer diagnosis excluding non-melanoma skin cancer. 2. Blood transfusion within the previous 6 months. 3. Immune suppression, such as HIV disease or immune-suppressing therapy (i.e., steroids).
References
Publications (0)
Data not yet available
No reference posted for this study.